Redwood Financial Network Corp Gilead Sciences, Inc. Transaction History

Redwood Financial Network Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $189,402 - $214,787	2,585 New	2,585 $209,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $16,038 - $18,293	-211 Reduced 7.33%	2,666 $205,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $309 - $352	4 Added 0.14%	2,877 $238,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $179,045 - $257,047	2,873 New	2,873 $246,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Redwood Financial Network Corp, based on Form 13F filings with the SEC.

Stay updated on Redwood Financial Network Corp with notifications on news.